News
FDA Approves First Twice-a-Year HIV Prevention Shot
FRIDAY, June 20, 2025 (HealthDay News) — A new shot to prevent HIV infection has just been approved — and it only needs to be taken twice a year. On Wednesday, the U.S. Food and Drug Administration (FDA) approved lenacapavir, a long-acting injection that was shown to be nearly 100% effective in clinical trials.
The National Institutes of Health office responsible for issuing federal guidelines related to treatment of HIV and AIDS ...
HIV and global health activists say the deployment of Gilead’s twice-a-year HIV prevention shot is the world’s best chance to ...
In a song out during Pride month and ahead of HIV testing day on June 27, a Nashville country singer discusses his own ...
The approach employed by the research team could be used against other diseases—including COVID-19 and influenza.
The drug, lamivudine, appears to improve vision that’s being threatened by diabetic macular edema (DME), an eye condition in ...
HIV is surging among adults over 50 in sub-Saharan Africa, yet prevention and treatment campaigns still focus mainly on the ...
The Food and Drug Administration has approved a highly effective new HIV-prevention medication, Gilead Sciences reported Wednesday. In clinical trials, the drug nearly eliminated HIV’s spread ...
Over 1,200 individuals gathered at Kapiʻolani Park on June 21 to participate in the 34th annual Walk for Life, Honolulu’s ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback